FDA rejects serelaxin for acute heart failure
Posted on: 16/05/2014 - 21:45
The Food and Drug Administration has decided that more evidence of serelaxin’s efficacy as a treatment for acute heart failure is needed before the drug can be approved in the United States, Novartis...
Field of Interest: Cardiology
Type: News Item